Next Article in Journal
A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting
Next Article in Special Issue
The Inflammasomes Adaptor Protein PYCARD Is a Potential Pyroptosis Biomarker Related to Immune Response and Prognosis in Clear Cell Renal Cell Carcinoma
Previous Article in Journal
Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization
Previous Article in Special Issue
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study
 
 
Article

Article Versions Notes

Cancers 2022, 14(12), 2972; https://doi.org/10.3390/cancers14122972
Action Date Notes Link
article pdf uploaded. 16 June 2022 13:43 CEST Version of Record https://www.mdpi.com/2072-6694/14/12/2972/pdf-vor
article xml file uploaded 22 June 2022 10:47 CEST Original file -
article xml uploaded. 22 June 2022 10:47 CEST Update https://www.mdpi.com/2072-6694/14/12/2972/xml
article pdf uploaded. 22 June 2022 10:47 CEST Updated version of record https://www.mdpi.com/2072-6694/14/12/2972/pdf
article html file updated 22 June 2022 10:48 CEST Original file -
article html file updated 22 June 2022 10:49 CEST Update -
article html file updated 23 June 2022 09:58 CEST Update -
article html file updated 12 August 2022 20:47 CEST Update https://www.mdpi.com/2072-6694/14/12/2972/html
Back to TopTop